Outcomes of Transjugular Intrahepatic Portosystemic Shunts for Ascites

Abstract

Refractory ascites represents a devastating complication of portal hypertension. Transjugular intrahepatic portosystemic shunt (TIPS) is an efficacious option for patients for whom transplant is not an immediate option. Techniques to optimize the hepatic venous pressure gradient and the use of covered stents have reduced rates of hepatic encephalopathy and stent occlusion, respectively. Patients with a Model for End-Stage Liver Disease score less than 15, serum creatinine less than 2 mg/dL, and serum bilirubin less than 2 mg/dL are particularly suited for TIPS placement. TIPS is also effective for hepatic hydrothorax and for massive ascites in the posttransplant setting, although future investigations are necessary to elucidate risk factors and establish the effect on transplant-free survival.

Keywords

portal hypertension - refractory ascites - transjugular intrahepatic portosystemic shunt - hepatic hydrothorax - liver transplant - interventional radiology

• References

• 1 Cichoz-Lach H, Celiński K, Słomka M, Kasztelan-Szczerbińska B. Pathophysiology of portal hypertension. J Physiol Pharmacol 2008; 59 (Suppl. 02) 231-238
• 2 de Franchis R ; Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53 (4) 762-768
• 3 de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43 (1) 167-176
• 4 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44 (1) 217-231
• 5 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W ; Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46 (3) 922-938
• 6 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD ; Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 2007; 102 (9) 2086-2102
• 7 Tsai MH. Splanchnic and systemic vasodilatation: the patient. J Clin Gastroenterol 2007; 41 (Suppl. 03) S266-S271
• 8 Dib N, Oberti F, Calès P. Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ 2006; 174 (10) 1433-1443
• 9 Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001; 120 (3) 726-748
• 10 Arroyo V, Rodés J. A rational approach to the treatment of ascites. Postgrad Med J 1975; 51 (598) 558-562
• 11 Khungar V, Saab S. Cirrhosis with refractory ascites: serial large volume paracentesis, TIPS, or transplantation?. Clin Gastroenterol Hepatol 2011; 9 (11) 931-935 , quiz e121–e122
• 12 Owen AR, Stanley AJ, Vijayananthan A, Moss JG. The transjugular intrahepatic portosystemic shunt (TIPS). Clin Radiol 2009; 64 (7) 664-674
• 13 Ginés P, Quintero E, Arroyo V , et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7 (1) 122-128
• 14 Arroyo V, Ginès A, Saló J. A European survey on the treatment of ascites in cirrhosis. J Hepatol 1994; 21 (4) 667-672
• 15 Garcia N, Sanyal AJ. Ascites. Curr Treat Options Gastroenterol 2001; 4 (6) 527-537
• 16 Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int 2012; 32 (9) 1407-1414
• 17 Weinstein MP, Iannini PB, Stratton CW, Eickhoff TC. Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med 1978; 64 (4) 592-598
• 18 Moore KP, Wong F, Gines P , et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38 (1) 258-266
• 19 Senousy BE, Draganov PV. Evaluation and management of patients with refractory ascites. World J Gastroenterol 2009; 15 (1) 67-80
• 20 Rössle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 2010; 59 (7) 988-1000
• 21 Russo MW, Sood A, Jacobson IM, Brown Jr RS. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality. Am J Gastroenterol 2003; 98 (11) 2521-2527
• 22 Ginès P, Uriz J, Calahorra B , et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123 (6) 1839-1847
• 23 Boyer TD. Transjugular intrahepatic portosystemic shunt in the management of complications of portal hypertension. Curr Gastroenterol Rep 2008; 10 (1) 30-35
• 24 Busk TM, Bendtsen F, Møller S. Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis. Eur J Gastroenterol Hepatol 2013; 25 (5) 523-530
• 25 Garcia-Tsao G. Transjugular intrahepatic portosystemic shunt in the management of refractory ascites. Semin Intervent Radiol 2005; 22 (4) 278-286
• 26 LaBerge JM. Transjugular intrahepatic portosystemic shunt—role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax. Clin Liver Dis 2006; 10 (3) 583-598 , ix
• 27 Narahara Y, Kanazawa H, Fukuda T , et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol 2011; 46 (1) 78-85
• 28 Saab S, Nieto JM, Lewis SK, Runyon BA. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev 2006; CD004889
• 29 Salerno F, Cammà C, Enea M, Rössle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 2007; 133 (3) 825-834
• 30 Albillos A, Bañares R, González M, Catalina MV, Molinero LM. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol 2005; 43 (6) 990-996
• 31 D'Amico G, Luca A, Morabito A, Miraglia R, D'Amico M. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology 2005; 129 (4) 1282-1293
• 32 Thalheimer U, Leandro G, Samonakis DN , et al. TIPS for refractory ascites: a single-centre experience. J Gastroenterol 2009; 44 (10) 1089-1095
• 33 Harrod-Kim P, Saad WE, Waldman D. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites. J Vasc Interv Radiol 2006; 17 (10) 1605-1610
• 34 Sanyal AJ. Pros and cons of TIPS for refractory ascites. J Hepatol 2005; 43 (6) 924-925
• 35 Bureau C, Métivier S, D'Amico M , et al. Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS. J Hepatol 2011; 54 (5) 901-907
• 36 Wu X, Ding W, Cao J, Fan X, Li J. Clinical outcome using the fluency stent graft for transjugular intrahepatic portosystemic shunt in patients with portal hypertension. Am Surg 2013; 79 (3) 305-312
• 37 Dhanasekaran R, Gonzales P, West JK , et al. Abstract no. 82: transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites. J Vasc Interv Radiol 2010; 21: S33
• 38 Guevara M, Baccaro ME, Ríos J , et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int 2010; 30 (8) 1137-1142
• 39 Tripathi D, Redhead D. Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments. Eur J Gastroenterol Hepatol 2006; 18 (11) 1127-1133
• 40 Bhogal HK, Sanyal AJ. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol 2011; 9 (11) 936-946 , quiz e123
• 41 Boyer TD, Haskal ZJ ; American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010; 51 (1) 306
• 42 Bureau C, Garcia-Pagan JC, Otal P , et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126 (2) 469-475
• 43 Bureau C, Pagan JCG, Layrargues GP , et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 2007; 27 (6) 742-747
• 44 Clark W, Golkar F, Luberice K , et al. Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts?. Am J Surg 2011; 202 (5) 561-564
• 45 Tripathi D, Ferguson J, Barkell H , et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol 2006; 18 (3) 225-232
• 46 Bureau C. Covered stents for TIPS: are all problems solved?. Eur J Gastroenterol Hepatol 2006; 18 (6) 581-583
• 47 Membreno F, Baez AL, Pandula R, Walser E, Lau DTY. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed. J Gastroenterol Hepatol 2005; 20 (3) 474-481
• 48 Ockenga J, Ockenga T, Kroencke T , et al. 222 cost analysis of E-PTFE covered tips stents compared to bare stents. J Hepatol 2004; 40: 71
• 49 Morrow CS, Kantor M, Armen RN. Hepatic hydrothorax. Ann Intern Med 1958; 49 (1) 193-203
• 50 Gordon FD, Anastopoulos HT, Crenshaw W , et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997; 25 (6) 1366-1369
• 51 Islam N, Ali S, Kabir H. Hepatic hydrothorax. Br J Dis Chest 1965; 59 (4) 222-227
• 52 Sherlock S, Dooley J. Diseases of the Liver and Biliary System. Chichester, GBR: Wiley; 2008
• 53 Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther 2004; 20 (3) 271-279
• 54 Rubinstein D, McInnes IE, Dudley FJ. Hepatic hydrothorax in the absence of clinical ascites: diagnosis and management. Gastroenterology 1985; 88 (1 Pt 1): 188-191
• 55 Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rössle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001; 13 (5) 529-534
• 56 Andrade RJ, Martin-Palanca A, Fraile JM , et al. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites. J Clin Gastroenterol 1996; 22 (4) 305-307
• 57 Saad WE, Wagner CC, Lippert A , et al. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol 2013; 108 (10) 1612-1619
• 58 Urbani L, Catalano G, Cioni R , et al. Management of massive and persistent ascites and/or hydrothorax after liver transplantation. Transplant Proc 2003; 35 (4) 1473-1475
• 59 Abouljoud M, Yoshida A, Kim D , et al. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation. Transplant Proc 2005; 37 (2) 1248-1250
• 60 Saad WEA, Davies MG, Lee DE , et al. Transjugular intrahepatic portosystemic shunt in a living donor left lateral segment liver transplant recipient: technical considerations. J Vasc Interv Radiol 2005; 16 (6) 873-877
• 61 Lerut JP, Laterre PF, Goffette P , et al. Transjugular intrahepatic portosystemic shunt and liver transplantation. Transpl Int 1996; 9 (4) 370-375
• 62 Somberg KA, Lombardero MS, Lawlor SM , et al; The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database. A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. Transplantation 1997; 63 (8) 1074-1079
• 63 Choi DX, Jain AB, Orloff MS. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients. J Am Coll Surg 2009; 208 (4) 539-546
• 64 Saad WEA, Darwish WM, Davies MG , et al. Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. AJR Am J Roentgenol 2013; 200 (1) 210-218